Daewon Pharmaceutical Adds 'Upper Respiratory Tract Infection' Indication to Kodaewon S Syrup

The Nation's First 5-Ingredient Combination Cough Expectorant

Daewon Pharmaceutical announced on the 4th that the indication for 'upper respiratory tract infection' has been added to 'KoDaewon S Syrup,' a five-ingredient combined antitussive and expectorant developed domestically for the first time.

Daewon Pharmaceutical announced that the indication for "upper respiratory tract infection" has been added to 'Kodaewon S Syrup,' a 5-component combination expectorant and antitussive developed for the first time in Korea. Kodaewon S Syrup.
[Photo by Daewon Pharmaceutical]

With this, KoDaewon S Syrup now has the additional indication of 'cough and sputum due to acute upper respiratory tract infection' alongside the existing indication for 'improvement of symptoms and signs of acute bronchitis,' enabling broader prescriptions for acute respiratory diseases.

While most antitussive and expectorant drugs released since 2020 are only prescribed for patients with acute bronchitis, Daewon Pharmaceutical emphasized that KoDaewon S Syrup was the first to expand its indication to allow prescriptions for patients with acute upper respiratory tract infection, making this development even more meaningful.

KoDaewon S Syrup was the first antitussive and expectorant to conduct clinical trials proving its superiority, demonstrating superiority compared to the control group. In the clinical trial for the addition of the upper respiratory tract infection indication, it satisfied non-inferiority through direct comparison with the control group and proved symptom improvement effects.

A Daewon Pharmaceutical official stated, "With this added indication, prescriptions can now be made for a wide range of symptoms such as cough and sputum caused by acute upper respiratory tract infection," adding, "We hope that more patients will be prescribed KoDaewon S Syrup, which has proven excellent efficacy and effectiveness, to quickly improve their symptoms."

KoDaewon S Syrup is a five-ingredient combination containing dihydrocodeine, chlorpheniramine, methylephedrine, ammonium chloride, and Pelargonium sidoides, a natural herbal ingredient with antibacterial and antiviral effects. Since its launch in 2020, its sales exceeded 30 billion KRW last year. In February, it also won the Technology Award in the New Drug Development category at the 24th Korea New Drug Development Awards ceremony.

This content was produced with the assistance of AI translation services.